Macwin Pharmaceuticals Private Limited - Charges

Every charge - open or closed - that lenders have registered against Macwin Pharmaceuticals Private Limited, with the most recent activity a…

2002-12-27 U T, Chandigarh Active Unlisted Active Compliant
Share
Connect MCP
MP Macwin Pharmaceuticals Private Limited
Open charges
1
55.00 Lakh
Closed charges
1
8.50 Lakh
Total
2
63.50 Lakh
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Others 1 55.00 Lakh
2 Punjab National Bank 1 8.50 Lakh
All charges (2) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
100615920 Others 23 Sep 2022 30 Jun 2025 - 55.00 Lakh Open
10501618 Punjab National Bank 04 Apr 2014 - 01 Sep 2022 8.50 Lakh Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Macwin Pharmaceuticals Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Macwin Pharmaceuticals Private Limited (CIN: U24232CH2002PTC025680). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Macwin Pharmaceuticals Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.